These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20938222)

  • 21. Diabetic bone disease. Low turnover osteoporosis related to decreased IGF-I production.
    Bouillon R
    Verh K Acad Geneeskd Belg; 1992; 54(4):365-91; discussion 391-2. PubMed ID: 1466160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
    Christiansen P
    APMIS Suppl; 2001; (102):1-52. PubMed ID: 11419022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrasting effects of parathyroid hormone and insulin-like growth factor I in an aged ovariectomized rat model of postmenopausal osteoporosis.
    Ibbotson KJ; Orcutt CM; D'Souza SM; Paddock CL; Arthur JA; Jankowsky ML; Boyce RW
    J Bone Miner Res; 1992 Apr; 7(4):425-32. PubMed ID: 1609630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PTH ameliorates acidosis-induced adverse effects in skeletal growth centers: the PTH-IGF-I axis.
    Green J; Goldberg R; Maor G
    Kidney Int; 2003 Feb; 63(2):487-500. PubMed ID: 12631114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GH and IGF-I as therapeutic agents for osteoporosis.
    Agnusdei D; Gentilella R
    J Endocrinol Invest; 2005; 28(8 Suppl):32-6. PubMed ID: 16323827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The expression of insulin-like growth factor-I mRNA and polypeptide in rat osteoblasts with exposure to parathyroid hormone.
    Zhang K; Chen J; Wang M; Wang C; Li G; Zheng Z; Zhao R
    Chin Med J (Engl); 2003 Dec; 116(12):1916-22. PubMed ID: 14687484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low dose recombinant human growth hormone normalizes bone metabolism and cortical bone density and improves trabecular bone density in growth hormone deficient adults without causing adverse effects.
    Amato G; Izzo G; La Montagna G; Bellastella A
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):27-32. PubMed ID: 8796135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth hormone and bone.
    Ohlsson C; Bengtsson BA; Isaksson OG; Andreassen TT; Slootweg MC
    Endocr Rev; 1998 Feb; 19(1):55-79. PubMed ID: 9494780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone.
    McCarthy TL; Centrella M; Canalis E
    Endocrinology; 1989 Mar; 124(3):1247-53. PubMed ID: 2645113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions between vitamin D and IGF-I: from physiology to clinical practice.
    Ameri P; Giusti A; Boschetti M; Murialdo G; Minuto F; Ferone D
    Clin Endocrinol (Oxf); 2013 Oct; 79(4):457-63. PubMed ID: 23789983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mechanisms of bone anabolic action by PTH].
    Kaji H
    Clin Calcium; 2012 Mar; 22(3):321-6. PubMed ID: 22370298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence that anabolic effects of PTH on bone require IGF-I in growing mice.
    Miyakoshi N; Kasukawa Y; Linkhart TA; Baylink DJ; Mohan S
    Endocrinology; 2001 Oct; 142(10):4349-56. PubMed ID: 11564695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benefits of growth hormone treatment on bone metabolism, bone density and bone strength in growth hormone deficiency and osteoporosis.
    Wüster C; Härle U; Rehn U; Müller C; Knauf K; Köppler D; Schwabe C; Ziegler R
    Growth Horm IGF Res; 1998 Feb; 8 Suppl A():87-94. PubMed ID: 10993598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth hormone replacement is important for the restoration of parathyroid hormone sensitivity and improvement in bone metabolism in older adult growth hormone-deficient patients.
    White HD; Ahmad AM; Durham BH; Patwala A; Whittingham P; Fraser WD; Vora JP
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3371-80. PubMed ID: 15741264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PTH Promotes Bone Anabolism by Stimulating Aerobic Glycolysis via IGF Signaling.
    Esen E; Lee SY; Wice BM; Long F
    J Bone Miner Res; 2015 Nov; 30(11):1959-68. PubMed ID: 25990470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bone and hormones. Effects of parathyroid hormone on the bone].
    Chevalley T; Rizzoli R
    Presse Med; 1999 Mar; 28(10):547-53. PubMed ID: 10209548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of impaired growth: effect of steroids on bone and cartilage.
    Olney RC
    Horm Res; 2009 Nov; 72 Suppl 1():30-5. PubMed ID: 19940493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-like growth factor 1 and parathyroid hormone effects on the growth of fetal rat metatarsal bones cultured in serum-free medium.
    Coxam V; Miller MA; Bowman BM; Qi D; Miller SC
    Biol Neonate; 1995; 68(5):368-76. PubMed ID: 8835091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does the GH/IGF-1 axis contribute to skeletal sexual dimorphism? Evidence from mouse studies.
    Liu Z; Mohan S; Yakar S
    Growth Horm IGF Res; 2016 Apr; 27():7-17. PubMed ID: 26843472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated serum IGF-1 levels synergize PTH action on the skeleton only when the tissue IGF-1 axis is intact.
    Elis S; Courtland HW; Wu Y; Fritton JC; Sun H; Rosen CJ; Yakar S
    J Bone Miner Res; 2010 Sep; 25(9):2051-8. PubMed ID: 20499370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.